Cargando…

Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000

In Cameroon, COVID-19 infection spread rapidly and nationwide, with up to 721 deaths reported. To the best of our knowledge, no study reported the on-theground data using a large patients’ dataset to give a comprehensive knowledge on COVID-19 pandemic in Cameroon. The objective of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fokam, Joseph, Takou, Désiré, Nka, Alex Durand, Ka’e, Aude Christelle, Yagai, Bouba, Ambe Chenwi, Collins, Ngoufack Jagni Semengue, Ezechiel, Angong Beloumou, Grâce, Djupsa Ndjeyep, Sandrine Claire, Abba, Aissatou, Pabo, Willy, Gouissi, Davy, Tommo Tchouaket, Michel Carlos, Yatchou, Laeticia, Zam, Krystel, Mama, Lucien, Ekitti, Regine Claudette, Fainguem, Nadine, Kamgaing, Rachel, Sosso, Samuel Martin, Ndembi, Nicaise, Colizzi, Vittorio, Perno, Carlo-Federico, Ndjolo, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202463/
https://www.ncbi.nlm.nih.gov/pubmed/35720804
http://dx.doi.org/10.4081/jphia.2022.2142
_version_ 1784728537086820352
author Fokam, Joseph
Takou, Désiré
Nka, Alex Durand
Ka’e, Aude Christelle
Yagai, Bouba
Ambe Chenwi, Collins
Ngoufack Jagni Semengue, Ezechiel
Angong Beloumou, Grâce
Djupsa Ndjeyep, Sandrine Claire
Abba, Aissatou
Pabo, Willy
Gouissi, Davy
Tommo Tchouaket, Michel Carlos
Yatchou, Laeticia
Zam, Krystel
Mama, Lucien
Ekitti, Regine Claudette
Fainguem, Nadine
Kamgaing, Rachel
Sosso, Samuel Martin
Ndembi, Nicaise
Colizzi, Vittorio
Perno, Carlo-Federico
Ndjolo, Alexis
author_facet Fokam, Joseph
Takou, Désiré
Nka, Alex Durand
Ka’e, Aude Christelle
Yagai, Bouba
Ambe Chenwi, Collins
Ngoufack Jagni Semengue, Ezechiel
Angong Beloumou, Grâce
Djupsa Ndjeyep, Sandrine Claire
Abba, Aissatou
Pabo, Willy
Gouissi, Davy
Tommo Tchouaket, Michel Carlos
Yatchou, Laeticia
Zam, Krystel
Mama, Lucien
Ekitti, Regine Claudette
Fainguem, Nadine
Kamgaing, Rachel
Sosso, Samuel Martin
Ndembi, Nicaise
Colizzi, Vittorio
Perno, Carlo-Federico
Ndjolo, Alexis
author_sort Fokam, Joseph
collection PubMed
description In Cameroon, COVID-19 infection spread rapidly and nationwide, with up to 721 deaths reported. To the best of our knowledge, no study reported the on-theground data using a large patients’ dataset to give a comprehensive knowledge on COVID-19 pandemic in Cameroon. The objective of this study was to shade lights on the epidemiological, virological and clinical features of COVID-19 in the Cameroonian context. An observational study was conducted among symptomatic and asymptomatic individuals tested for SARS-CoV-2 by PCR on nasopharyngeal samples from April 22(nd), 2020 to January 5(th), 2021. Out of 14119 individuals (59.8% male), overall SARS-CoV-2 positivity was 12.7% (from 7.9% in <10 years to 17.3% in >60 years, p<0.001). The positivity rate of symptomatic individuals was 36.1% versus 9.8% among asymptomatic ones, p<0.001. Age group ≤10 [aOR (95%CI): 0.515 (0.338-0.784), p=0.002] and being symptomatic [aOR (95% CI): 5.108 (4.521-5.771), p<0.001] were predictors of SARS-CoV-2 positivity. Regarding PCR Cycle Threshold (CT), 53.8% of positive individuals had a CT <30. According to age, compared to older individuals, those aged 21-40 years showed a higher proportion with high viraemia (CT<20; 21.3% versus 12.5% respectively, p=0.003). Similarly, symptomatic individuals showed a higher proportion with high viraemia (22.4%), when compared to asymptomatic (13.9%); p<0.001. During this first wave of the pandemic, overall SARS-CoV-2 positivity remained high (>10%) and was associated with the presence of symptoms and older age. Most of the infection is among young and asymptomatic individuals, suggesting the “track-and-test” strategy should target these potential transmitters.
format Online
Article
Text
id pubmed-9202463
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-92024632022-06-17 Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000 Fokam, Joseph Takou, Désiré Nka, Alex Durand Ka’e, Aude Christelle Yagai, Bouba Ambe Chenwi, Collins Ngoufack Jagni Semengue, Ezechiel Angong Beloumou, Grâce Djupsa Ndjeyep, Sandrine Claire Abba, Aissatou Pabo, Willy Gouissi, Davy Tommo Tchouaket, Michel Carlos Yatchou, Laeticia Zam, Krystel Mama, Lucien Ekitti, Regine Claudette Fainguem, Nadine Kamgaing, Rachel Sosso, Samuel Martin Ndembi, Nicaise Colizzi, Vittorio Perno, Carlo-Federico Ndjolo, Alexis J Public Health Afr Article In Cameroon, COVID-19 infection spread rapidly and nationwide, with up to 721 deaths reported. To the best of our knowledge, no study reported the on-theground data using a large patients’ dataset to give a comprehensive knowledge on COVID-19 pandemic in Cameroon. The objective of this study was to shade lights on the epidemiological, virological and clinical features of COVID-19 in the Cameroonian context. An observational study was conducted among symptomatic and asymptomatic individuals tested for SARS-CoV-2 by PCR on nasopharyngeal samples from April 22(nd), 2020 to January 5(th), 2021. Out of 14119 individuals (59.8% male), overall SARS-CoV-2 positivity was 12.7% (from 7.9% in <10 years to 17.3% in >60 years, p<0.001). The positivity rate of symptomatic individuals was 36.1% versus 9.8% among asymptomatic ones, p<0.001. Age group ≤10 [aOR (95%CI): 0.515 (0.338-0.784), p=0.002] and being symptomatic [aOR (95% CI): 5.108 (4.521-5.771), p<0.001] were predictors of SARS-CoV-2 positivity. Regarding PCR Cycle Threshold (CT), 53.8% of positive individuals had a CT <30. According to age, compared to older individuals, those aged 21-40 years showed a higher proportion with high viraemia (CT<20; 21.3% versus 12.5% respectively, p=0.003). Similarly, symptomatic individuals showed a higher proportion with high viraemia (22.4%), when compared to asymptomatic (13.9%); p<0.001. During this first wave of the pandemic, overall SARS-CoV-2 positivity remained high (>10%) and was associated with the presence of symptoms and older age. Most of the infection is among young and asymptomatic individuals, suggesting the “track-and-test” strategy should target these potential transmitters. PAGEPress Publications, Pavia, Italy 2022-05-24 /pmc/articles/PMC9202463/ /pubmed/35720804 http://dx.doi.org/10.4081/jphia.2022.2142 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0).
spellingShingle Article
Fokam, Joseph
Takou, Désiré
Nka, Alex Durand
Ka’e, Aude Christelle
Yagai, Bouba
Ambe Chenwi, Collins
Ngoufack Jagni Semengue, Ezechiel
Angong Beloumou, Grâce
Djupsa Ndjeyep, Sandrine Claire
Abba, Aissatou
Pabo, Willy
Gouissi, Davy
Tommo Tchouaket, Michel Carlos
Yatchou, Laeticia
Zam, Krystel
Mama, Lucien
Ekitti, Regine Claudette
Fainguem, Nadine
Kamgaing, Rachel
Sosso, Samuel Martin
Ndembi, Nicaise
Colizzi, Vittorio
Perno, Carlo-Federico
Ndjolo, Alexis
Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000
title Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000
title_full Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000
title_fullStr Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000
title_full_unstemmed Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000
title_short Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000
title_sort epidemiological, virological and clinical features of sars-cov-2 among individuals during the first wave in cameroon: baseline analysis for the edctp perfect-study ria2020ef-3000
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202463/
https://www.ncbi.nlm.nih.gov/pubmed/35720804
http://dx.doi.org/10.4081/jphia.2022.2142
work_keys_str_mv AT fokamjoseph epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT takoudesire epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT nkaalexdurand epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT kaeaudechristelle epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT yagaibouba epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT ambechenwicollins epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT ngoufackjagnisemengueezechiel epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT angongbeloumougrace epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT djupsandjeyepsandrineclaire epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT abbaaissatou epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT pabowilly epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT gouissidavy epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT tommotchouaketmichelcarlos epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT yatchoulaeticia epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT zamkrystel epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT mamalucien epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT ekittiregineclaudette epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT fainguemnadine epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT kamgaingrachel epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT sossosamuelmartin epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT ndembinicaise epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT colizzivittorio epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT pernocarlofederico epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000
AT ndjoloalexis epidemiologicalvirologicalandclinicalfeaturesofsarscov2amongindividualsduringthefirstwaveincameroonbaselineanalysisfortheedctpperfectstudyria2020ef3000